Pharmacology and Therapeutics of Asthma and COPD
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2017.
|
| Edición: | 1st ed. 2017. |
| Colección: | Handbook of Experimental Pharmacology,
237 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-3-319-52175-6 |
Tabla de Contenidos:
- Pathogenesis of bronchial asthma and chronic obstructive pulmonary disease – common diseases with unmet needs
- Beta 2 agonists
- Muscarinic receptor antagonists
- Xanthines and Phosphodiesterase inhibitors
- Glucocorticosteroids
- Fixed dose combination inhalers
- Anti-IgE and biologic approaches for the treatment of asthma
- Leukotriene receptor antagonists and anti-allergy drugs
- Novel anti-inflammatory drugs
- Bifunctional drugs for the treatment of respiratory diseases
- Drugs affecting TRP channels
- Evaluation of new drugs for asthma and COPD: endpoints, biomarkers and clinical trial design
- Drug delivery devices for inhaled medicines. .